Standard
Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer. / Almasi, Charlotte E; Brasso, Klaus; Iversen, Peter; Pappot, Helle; Høyer-Hansen, Gunilla; Danø, Keld; Christensen, Ib J.
I:
The Prostate, Bind 71, Nr. 8, 01.06.2011, s. 899-907.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Almasi, CE, Brasso, K, Iversen, P
, Pappot, H, Høyer-Hansen, G, Danø, K & Christensen, IJ 2011, '
Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer',
The Prostate, bind 71, nr. 8, s. 899-907.
https://doi.org/10.1002/pros.21306APA
Almasi, C. E., Brasso, K., Iversen, P.
, Pappot, H., Høyer-Hansen, G., Danø, K., & Christensen, I. J. (2011).
Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer.
The Prostate,
71(8), 899-907.
https://doi.org/10.1002/pros.21306Vancouver
Almasi CE, Brasso K, Iversen P
, Pappot H, Høyer-Hansen G, Danø K o.a.
Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer.
The Prostate. 2011 jun. 1;71(8):899-907.
https://doi.org/10.1002/pros.21306Author
Almasi, Charlotte E ; Brasso, Klaus ; Iversen, Peter ; Pappot, Helle ; Høyer-Hansen, Gunilla ; Danø, Keld ; Christensen, Ib J. / Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer. I: The Prostate. 2011 ; Bind 71, Nr. 8. s. 899-907.
Bibtex
@article{c8dbb3a4cfc4452eae010f1fe6e5cb50,
title = "Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer",
abstract = "The purpose of this study was to investigate the prognostic value of different forms of the urokinase receptor, uPAR, in serum from prostate cancer (PC) patients.",
keywords = "Aged, Aged, 80 and over, Androgen Antagonists, Bone Neoplasms, Carcinoma, Estradiol, Humans, Male, Middle Aged, Prognosis, Prostatic Neoplasms, Randomized Controlled Trials as Topic, Receptors, Urokinase Plasminogen Activator, Retrospective Studies, Treatment Outcome",
author = "Almasi, {Charlotte E} and Klaus Brasso and Peter Iversen and Helle Pappot and Gunilla H{\o}yer-Hansen and Keld Dan{\o} and Christensen, {Ib J}",
note = "Copyright {\textcopyright} 2010 Wiley-Liss, Inc.",
year = "2011",
month = jun,
day = "1",
doi = "10.1002/pros.21306",
language = "English",
volume = "71",
pages = "899--907",
journal = "The Prostate. Supplement",
issn = "0270-4137",
publisher = "JohnWiley & Sons, Inc.",
number = "8",
}
RIS
TY - JOUR
T1 - Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer
AU - Almasi, Charlotte E
AU - Brasso, Klaus
AU - Iversen, Peter
AU - Pappot, Helle
AU - Høyer-Hansen, Gunilla
AU - Danø, Keld
AU - Christensen, Ib J
N1 - Copyright © 2010 Wiley-Liss, Inc.
PY - 2011/6/1
Y1 - 2011/6/1
N2 - The purpose of this study was to investigate the prognostic value of different forms of the urokinase receptor, uPAR, in serum from prostate cancer (PC) patients.
AB - The purpose of this study was to investigate the prognostic value of different forms of the urokinase receptor, uPAR, in serum from prostate cancer (PC) patients.
KW - Aged
KW - Aged, 80 and over
KW - Androgen Antagonists
KW - Bone Neoplasms
KW - Carcinoma
KW - Estradiol
KW - Humans
KW - Male
KW - Middle Aged
KW - Prognosis
KW - Prostatic Neoplasms
KW - Randomized Controlled Trials as Topic
KW - Receptors, Urokinase Plasminogen Activator
KW - Retrospective Studies
KW - Treatment Outcome
U2 - 10.1002/pros.21306
DO - 10.1002/pros.21306
M3 - Journal article
C2 - 21456072
VL - 71
SP - 899
EP - 907
JO - The Prostate. Supplement
JF - The Prostate. Supplement
SN - 0270-4137
IS - 8
ER -
